drugset / Trial / NCT03849612

A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus

NCT03849612

Completed 10 enrolled Eli Lilly and Company
NaSingle-groupOpen-labelDevice feasibility

Summary

The purpose of this study is to evaluate whether an Automated Insulin Delivery (AID) System is safe to use and functions as intended with personalized basal insulin rates and when basal insulin rates are increased.

Timeline

Start
2019-02-21
Primary completion
2019-03-27
Completion
2019-03-27

Drugs

EvaluationDrugModalityDoseRoute
Background Insulin Lispro Protein / enzyme biologic Subcutaneous